» Articles » PMID: 34066487

Mixing Cells for Vascularized Kidney Regeneration

Overview
Journal Cells
Publisher MDPI
Date 2021 Jun 2
PMID 34066487
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The worldwide rise in prevalence of chronic kidney disease (CKD) demands innovative bio-medical solutions for millions of kidney patients. Kidney regenerative medicine aims to replenish tissue which is lost due to a common pathological pathway of fibrosis/inflammation and rejuvenate remaining tissue to maintain sufficient kidney function. To this end, cellular therapy strategies devised so far utilize kidney tissue-forming cells (KTFCs) from various cell sources, fetal, adult, and pluripotent stem-cells (PSCs). However, to increase engraftment and potency of the transplanted cells in a harsh hypoxic diseased environment, it is of importance to co-transplant KTFCs with vessel forming cells (VFCs). VFCs, consisting of endothelial cells (ECs) and mesenchymal stem-cells (MSCs), synergize to generate stable blood vessels, facilitating the vascularization of self-organizing KTFCs into renovascular units. In this paper, we review the different sources of KTFCs and VFCs which can be mixed, and report recent advances made in the field of kidney regeneration with emphasis on generation of vascularized kidney tissue by cell transplantation.

Citing Articles

Porcine Kidney Organoids Derived from Naïve-like Embryonic Stem Cells.

Li M, Guo X, Cheng L, Zhang H, Zhou M, Zhang M Int J Mol Sci. 2024; 25(1).

PMID: 38203853 PMC: 10779635. DOI: 10.3390/ijms25010682.


A review of the evidence to support electrical stimulationinduced vascularization in engineered tissue.

Wang Y, Meng X Regen Ther. 2023; 24:237-244.

PMID: 37534238 PMC: 10393514. DOI: 10.1016/j.reth.2023.07.005.


Engraftment of Kidney Organoids In Vivo.

Freedman B, Dekel B Curr Transplant Rep. 2023; 10(2):29-39.

PMID: 37128257 PMC: 10126570. DOI: 10.1007/s40472-023-00397-2.


Stem Cells to the Rescue: Development and Application of Cell-Based Therapy for Microvascular Repair.

Lerman L, Lerman A Cells. 2021; 10(8).

PMID: 34440914 PMC: 8393633. DOI: 10.3390/cells10082144.

References
1.
Koning M, van den Berg C, Rabelink T . Stem cell-derived kidney organoids: engineering the vasculature. Cell Mol Life Sci. 2019; 77(12):2257-2273. PMC: 7275011. DOI: 10.1007/s00018-019-03401-0. View

2.
Buzhor E, Harari-Steinberg O, Omer D, Metsuyanim S, Jacob-Hirsch J, Noiman T . Kidney spheroids recapitulate tubular organoids leading to enhanced tubulogenic potency of human kidney-derived cells. Tissue Eng Part A. 2011; 17(17-18):2305-19. DOI: 10.1089/ten.TEA.2010.0595. View

3.
Barry D, McMillan E, Kunar B, Lis R, Zhang T, Lu T . Molecular determinants of nephron vascular specialization in the kidney. Nat Commun. 2019; 10(1):5705. PMC: 6910926. DOI: 10.1038/s41467-019-12872-5. View

4.
Rama I, Grinyo J . Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010; 6(9):511-9. DOI: 10.1038/nrneph.2010.102. View

5.
Romagnani P, Remuzzi G, Glassock R, Levin A, Jager K, Tonelli M . Chronic kidney disease. Nat Rev Dis Primers. 2017; 3:17088. DOI: 10.1038/nrdp.2017.88. View